Bicarbonate

Bicarbonate

SCHEMBL6235903

O=C([O-])O.O=C([O-])[O-].[Li+].[Li+].[Li+]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Bicarbonate. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CA4 P22748 5/20 0.42
CA1 P00915 3/20 0.42
FAHD1 Q6P587 1/20 0.42
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
LMNA P02545 2/20 0.33
KDM5B Q9UGL1 1/20 0.33
MEN1 O00255 1/20 0.33
LDHA P00338 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.33
ACHE P22303 1/20 0.33
FFAR3 O14843 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
OR51E2 Q9H255 1/20 0.31
CASP1 P29466 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bicarbonate SCHEMBL28072623 0.95 CA4 (0.39) CA4CA1FAHD1CA2CA9
Bicarbonate SCHEMBL29098772 0.95 CA4 (0.39) CA4CA1FAHD1CA2CA9
Bicarbonate SCHEMBL7924520 0.95 CA4 (0.39) CA4CA1FAHD1CA2CA9
Bicarbonate SCHEMBL28090789 0.95 CA4 (0.39) CA4CA1FAHD1CA2CA9
Bicarbonate SCHEMBL15662074 0.95 CA4 (0.50) CA4CA1FAHD1CA2CA9
Bicarbonate SCHEMBL25396149 0.95 CA4 (0.39) CA4CA1FAHD1CA2CA9
Bicarbonate SCHEMBL5140509 0.95 CA4 (0.50) CA4CA1FAHD1CA2CA9
Bicarbonate SCHEMBL15662076 0.95 CA4 (0.50) CA4CA1FAHD1CA2CA9
Bicarbonate SCHEMBL30997 0.94
Bicarbonate SCHEMBL6235909 0.94 CA4 (0.46) CA4CA1FAHD1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050090675-A1 Process for preparing highly pure androstane 17-beta-carboxylic acids and 17-beta-carbothioic acid fluoromethyl esters thereof S.N.I.F.F. ITALIA S.P.A. (IT) 2005-04-28 US disclosed
EP-1526139-A1 A process for preparing highly pure androstane 17-beta-carboxylic acids and androstane 17-beta-carbothioic acid fluoromethyl esters S.N.I.F.F. Italia S.P.A. (IT) 2005-04-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090675-A1 Process for preparing highly pure androstane 17-beta-carboxylic acids and 17-beta-carbothioic acid fluoromethyl esters thereof CYP17A1, HSD17B11, HSD17B7 CA4 311/4885CA1 55/4885FAHD1 1074/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.